Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Author
Viveka Roychowdhury
‘The government could do more in terms of how it sees research activities’
The government is doing many positive things in the biosciences, but could do more, in terms of how it sees research activities,…
Learnings from the GVK BIO saga
Now that India’s competition watch dog, the Competition Commission of India (CCI) has given its nod to Sun Pharma’s acquisition of…
UBM India, Express Pharma organise panel discussion
The panel discussed impediments and opportunities facing Indian pharma as it transitioned form a volumes to a value play
UBM India announces India Pharma Awards
The Awards ceremony will be preceded by a panel discussion on 'From Volumes to Value Play: Towards Achieving Vision 2020'
‘We will launch INSTACOAT 4G at CPhI India 2014’
Suresh Pareek, Managing Director, Ideal Cures reveals his strategies and expectations from the CPhI India 2014 show, in an…
‘The government could do more, in terms of how it sees research activities’
The government is doing many positive things in the biosciences, but could do more, in terms of how it sees research activities,…
‘In increasingly crowded markets like India, a recognised and trusted corporate brand is critical’
After the hiving off of its proprietary pharmaceuticals business, about half of the new Abbott’s business is either direct to…
Looking back, moving forward
Sometimes, the more things change, the more they remain the same. Express Pharma Pulse was launched in December 1994. Change was…
Peering into the crystal ball
As we discussed themes for Express Pharma’s 20th Anniversary series which kicks off with the December 1-15 issue, we were struck…